NIBEC Co. Ltd (138610) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.065x

Based on the latest financial reports, NIBEC Co. Ltd (138610) has a cash flow conversion efficiency ratio of -0.065x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.00 Billion ≈ $-2.03 Million USD) by net assets (₩45.82 Billion ≈ $31.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

NIBEC Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how NIBEC Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 138610 total liabilities for a breakdown of total debt and financial obligations.

NIBEC Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NIBEC Co. Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Asia Sermkij Leasing Public Company Limited
BK:ASK
0.261x
Siward Crystal Technology Co Ltd
TW:2484
0.029x
PAMT CORP
NASDAQ:PAMT
-0.028x
Pyridam Farma Tbk
JK:PYFA
-0.213x
Josef Manner & Comp. AG
VI:MAN
-0.126x
Loandepot Inc
NYSE:LDI
0.100x
China Ecotek Corp
TW:1535
0.039x
Sajodaerim
KO:003960
0.051x

Annual Cash Flow Conversion Efficiency for NIBEC Co. Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of NIBEC Co. Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see NIBEC Co. Ltd market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩45.82 Billion
≈ $31.05 Million
₩5.82 Billion
≈ $3.94 Million
0.127x +1305.36%
2024-12-31 ₩32.23 Billion
≈ $21.84 Million
₩291.25 Million
≈ $197.38K
0.009x +113.30%
2023-12-31 ₩28.84 Billion
≈ $19.55 Million
₩-1.96 Billion
≈ $-1.33 Million
-0.068x -145.98%
2022-12-31 ₩36.80 Billion
≈ $24.94 Million
₩5.44 Billion
≈ $3.69 Million
0.148x +394.14%
2021-12-31 ₩27.34 Billion
≈ $18.53 Million
₩817.97 Million
≈ $554.33K
0.030x +289.86%
2020-12-31 ₩31.84 Billion
≈ $21.58 Million
₩-501.66 Million
≈ $-339.97K
-0.016x +50.23%
2019-12-31 ₩27.40 Billion
≈ $18.57 Million
₩-867.62 Million
≈ $-587.97K
-0.032x +85.49%
2018-12-31 ₩10.58 Billion
≈ $7.17 Million
₩-2.31 Billion
≈ $-1.56 Million
-0.218x -578.82%
2017-12-31 ₩12.36 Billion
≈ $8.38 Million
₩563.22 Million
≈ $381.68K
0.046x +220.46%
2016-12-31 ₩9.84 Billion
≈ $6.67 Million
₩-372.21 Million
≈ $-252.24K
-0.038x +80.82%
2015-12-31 ₩10.82 Billion
≈ $7.33 Million
₩-2.13 Billion
≈ $-1.45 Million
-0.197x -10.83%
2014-12-31 ₩5.08 Billion
≈ $3.44 Million
₩-903.85 Million
≈ $-612.53K
-0.178x --

About NIBEC Co. Ltd

KQ:138610 Korea Biotechnology
Market Cap
$198.48 Million
₩292.88 Billion KRW
Market Cap Rank
#16556 Global
#699 in Korea
Share Price
₩25900.00
Change (1 day)
-3.90%
52-Week Range
₩19320.00 - ₩52300.00
All Time High
₩55200.00
About

NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is base… Read more